Steroids Drugs as An Adjunct for Reducing the Incidence of Proliferative Vitreoretinopathy After Rhegmatogenous Retinal Detachment Surgery: A Meta-analysis of Randomized Controlled Studies

被引:10
作者
Xu, Manhong [1 ,2 ]
Fan, Xiaoe [3 ]
Huang, Xinyuan [1 ,2 ]
Chen, Xin [1 ,2 ]
Shao, Yan [1 ,2 ]
Li, Xiaorong [1 ,2 ]
机构
[1] Tianjin Med Univ Eye Hosp, Eye Inst, Tianjin Branch, Tianjin Key Lab Retinal Funct & Dis,Natl Clin Res, Tianjin, Peoples R China
[2] Tianjin Med Univ Eye Hosp, Sch Optometry, Tianjin, Peoples R China
[3] Jincheng Peoples Hosp, Ophthalmol Dept, Jincheng, Shanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
MOLECULAR-WEIGHT HEPARIN; DEXAMETHASONE INTRAVITREAL IMPLANT; PARS-PLANA VITRECTOMY; TRIAMCINOLONE ACETONIDE; CONTROLLED-TRIAL; COMBINED; 5-FLUOROURACIL; RELEASE DEXAMETHASONE; MANAGEMENT; CORTICOSTEROIDS; INJECTION;
D O I
10.1159/000529451
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Introduction: The efficacy and influence of steroids for reducing the incidence of proliferative vitreoretinopathy (PVR) after rhegmatogenous retinal detachment (RRD) surgery remains controversial. Systematic review and meta-analysis were conducted to explore the effect of steroids versus placebo on risk of PVR.Methods: We searched PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through September 2020 for randomized controlled trials (RCTs) assessing the effect of steroids drugs as an adjunct for reducing the incidence of proliferative vitreoretinopathy after RRD surgery. This meta-analysis is performed using the random-effect model. The data were extracted by two reviewers independently, the quality of RCTs was assessed by the Cochrane risk of bias tool. We calculated risk ratio (RR) and the 95% confidence intervals (CIs) of all outcomes and plotted on forest plots. I-2 accessed using the chi-square test was applied to quantify the degree of heterogeneity.Results: Four RCTs involving 478 patients (478 eyes) are included in the meta-analysis. There was no significant difference in the incidence of PVR recurrence between steroid groups and control groups (RR 0.87, 95% CI 0.70-1.08, P=0.19). However, the incidence of recurrent PVR was lower in the steroids group (RR 0.67, 95% CI 0.46-0.99, P=0.04) than in the control group when only PVR grade A and B were taken into consideration. Besides, steroids could significantly reduce the incidence of macular edema after surgery (RR 0.64, 95% CI 0.47-0.88, P=0.007). Steroids group and control group had comparable outcomes of retinal reattachment rate and re-operation rate after primary surgery. Additionally, there was no significant difference of incidence of epiretinal membrane, and the incidence of surgery required by epiretinal membrane.Discussion/Conclusion: This meta-analysis reveals that RRD surgery combined with steroid drugs administration could significantly reduce the recurrence in PVR grade A and B subgroup, as well as the incidence of macular edema after surgery.
引用
收藏
页码:599 / 610
页数:12
相关论文
共 40 条
[1]   Pars plana vitrectomy with and without triamcinolone acetonide assistance in pseudophakic retinal detachment complicated with proliferative vitreoretinopathy [J].
Acar, Nur ;
Kapran, Ziya ;
Altan, Tugrul ;
Unver, Yaprak Banu ;
Pasaoglu, Ercan .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2010, 54 (04) :331-337
[2]   Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy A Randomized Clinical Trial [J].
Ahmadieh, Hamid ;
Feghhi, Mostafa ;
Tabatabaei, Homa ;
Shoeibi, Nasser ;
Ramezani, Alireza ;
Mohebbi, Mohammad Reza .
OPHTHALMOLOGY, 2008, 115 (11) :1938-1943
[3]   The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial [J].
Bali, Ernesto ;
Feron, Eric J. ;
Peperkamp, Ed ;
Veckeneer, Marc ;
Mulder, Paul G. ;
van Meurs, Jan C. .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (07) :957-962
[4]   Slow-Release Dexamethasone in Proliferative Vitreoretinopathy [J].
Banerjee, Philip J. ;
Quartilho, Ana ;
Bunce, Catey ;
Xing, Wen ;
Zvobgo, Tapiwa M. ;
Harris, Nicola ;
Charteris, David G. .
OPHTHALMOLOGY, 2017, 124 (06) :757-767
[5]   Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema [J].
Boyer, David S. ;
Yoon, Young Hee ;
Belfort, Rubens, Jr. ;
Bandello, Francesco ;
Maturi, Raj K. ;
Augustin, Albert J. ;
Li, Xiao-Yan ;
Cui, Harry ;
Hashad, Yehia ;
Whitcup, Scott M. .
OPHTHALMOLOGY, 2014, 121 (10) :1904-1914
[6]   Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences [J].
Carlos Pastor, J. ;
Rojas, Jimena ;
Pastor-Idoate, Salvador ;
Di Lauro, Salvatore ;
Gonzalez-Buendia, Lucia ;
Delgado-Tirado, Santiago .
PROGRESS IN RETINAL AND EYE RESEARCH, 2016, 51 :125-155
[7]   Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy [J].
Chang, Yo-Chen ;
Hu, Dan-Ning ;
Wu, Wen-Chuan .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 146 (03) :440-446
[8]   Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant [J].
Chang-Lin, Joan-En ;
Attar, Mayssa ;
Acheampong, Andrew A. ;
Robinson, Michael R. ;
Whitcup, Scott M. ;
Kuppermann, Baruch D. ;
Welty, Devin .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (01) :80-86
[9]   A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy [J].
Charteris, DG ;
Aylward, GW ;
Wong, D ;
Groenewald, C ;
Asaria, RHY ;
Bunce, C .
OPHTHALMOLOGY, 2004, 111 (12) :2240-2245
[10]   Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy [J].
Cheema, Rizwan A. ;
Peyman, Gholam A. ;
Fang, Ting ;
Jones, Andrew ;
Lukaris, Andrew D. ;
Lim, Kim .
OPHTHALMIC SURGERY LASERS & IMAGING, 2007, 38 (05) :365-370